DNA diagnostics is a cutting edge method which is set to revolutionize the field of medical diagnostics. This technique enables medical professionals to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for the same. It is also used for clinical diagnostic confirmation and in prenatal diagnostics. The concept of DNA diagnostics has evolved via the breakthrough human genome project that resulted in the discovery of various disease-causing agents. The DNA diagnostics market is expected to generate 19 billion by 2020, growing at a CAGR of 9.8% during the analysis period. Technological development has played a major role in improving DNA diagnostic platforms and techniques.
Some of the significant technologies which incorporate DNA diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology and mass spectrometry; these technologies are used for sample preparation, DNA isolation etc. Technological developments, which have led to improvements in these methodologies, drive the growth of the DNA diagnostics market. The use of DNA diagnostic methods in prenatal diagnostics and clinical confirmation has also boosted market growth. The DNA diagnostics market is expected to experience a growth spurt in the foreseeable future. Innovations in product design and technology have prompted doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines. The increased adoption of the personalized medicines approach would positively impact the DNA diagnostics market in the foreseeable future. Next generation sequencing is a powerful tool for decoding a number of human diseases, including various forms of cancer. Next generation sequencing reduces the cost of sequencing and increases the throughput. The optimization of sequencing technology could greatly impact the DNA diagnostics market.
The report breaks the market into segments based on product type, technology, application, end users and geography. Based on product types, the market is segmented into instruments, reagents and service & software. The instruments segment holds the dominant share in the market, due to improved healthcare facilities, availability of user-friendly instruments, its competitive cost structure, reliability, size and the growing demand for it in the DNA diagnostics market. However, the service & software segment is expected to grow at a steady rate in the near future due to technological advancements and the incorporation of information technology in the DNA diagnostics market. There are several technologies used in the DNA diagnostics market; these include PCR, mass spectrometry, sequencing technology, in-situ hybridization and microarrays. PCR holds the dominant share due to its frequent usage in diagnostic procedures such as sample preparation, separation and isolation of DNA from collected samples. The DNA diagnostics market is also segmented based on its application in various diseases such as oncology, infectious diseases and myogenic disorders. The oncology segment leads the market and is followed by infectious diseases due to the rising incidence of these diseases and growing elderly population. In terms of geography, the market is segmented into North America, Asia Pacific, Europe and LAMEA. North America holds the dominant share in the market due to the increased adoption of the DNA diagnostics technology and the high prevalence of chronic and infectious diseases. Companies profiled in the report include Roche Diagnostics, Bayer Diagnostic, Sysmex, Abbott laboratories, Gene-probe Inc., Cephide, Illumina, Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Johnson and Johnson, and Novartis.
KEY BENEFITS
MARKET SEGMENTATION:
The DNA diagnostics market is segmented based on product type, technology, application, end users and geography
MARKET BY PRODUCT TYPE
MARKET BY TECHNOLOGY
MARKET BY APPLICATION
MARKET BY END USERS
MARKET BY GEOGRAPHY
CHAPTER 1 INTRODUCTION
1.1 Report Description
1.2 Reason for doing the study
1.2.1 Key Benefits
1.2.2 Key Market Segments
1.2.3 Key Audiences
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.3.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond what to expect by 2025 ($Million)
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Application of biotechnology in DNA Diagnostic
3.3 Responsibility of Next-generation Sequencing technologies
3.4 Key Findings
3.4.1 Top Factors Impacting on DNA Diagnostics market
3.4.2 Top Investment Pockets of DNA Diagnostics market
3.4.3 Top winning strategies of DNA Diagnostics market
3.5 Government Regulations
3.5.1 FDA guidelines for personalized medicines
3.6 P orter’s Five force Analysis
3.6.1 Bargaining power of suppliers
3.6.2 Bargaining power of Buyers
3.6.3 Threat from new entrants
3.6.4 Threat of Substitute
3.6.5 Competitive Rivalry
3.7 Value chain analysis
3.7.1 Primary Activities
3.7.2 Supportive activities
3.8 Clinical Trials
3.9 Patent Analysis
3.9.1 Patent analysis by geographies(2010-2014)
3.9.2 Patent analysis by sub-segment (2010-2014)
3.10 Market Share Analysis,2013
3.11 Market Dynamics
3.11.1 Drivers
3.11.1.1 Increasing incidences of chronic and infectious diseases
3.11.1.2 Technological Advancements and product modification
3.11.1.3 Increase in popularity personalized medicine approach
3.11.2 Restraints
3.11.2.1 High cost involved in reaseach & development
3.11.2.2 Unclear reimbursement policies&stringent government regulation
3.11.3 Opportunities
3.11.3.1 Technological Development
3.11.3.2 Increasing need of Personalized Medicines
CHAPTER 4 GLOBAL DNA DIAGNOSTICS MARKET BY PRODUCT TYPES
4.1 Instruments
4.1.1 Key market trends
4.1.2 Competitive Scenario
4.1.3 Key growth factors and opportunities
4.1.4 Market size and forecast
4.2 Reagents
4.2.1 Key market trends
4.2.2 Competitive Scenario
4.2.1 Key growth factors and opportunities
4.2.2 Market size and forecast
4.3 Software & Services
4.3.1 Key market trends
4.3.1 Competitive Scenario
4.3.1 Key growth factors and opportunities
4.3.2 Market size and forecast
CHAPTER 5 GLOBAL DNA DIAGNOSTICS MARKET BY TECHNOLOGY, 2013-2020
5.1 PCR
5.1.1 Key market trends
5.1.2 Competitive scenario
5.1.3 Key growth factors and opportunities
5.1.4 Market size and forecast
5.2 Microarrays
5.2.1 Lab on chip
5.2.2 DNA microarray
5.2.3 Protein microarray
5.2.4 Key market trends
5.2.5 Competitive scenario
5.2.6 Key growth factors and opportunities
5.2.7 Market size and forecast
5.3 In situ hybridization
5.3.1 Key market trends
5.3.2 Competitive scenario
5.3.3 Key growth factors and opportunities
5.3.4 Market size and forecast
5.4 Sequencing Technology
5.4.1 Key market trends
5.4.2 Competitive scenario
5.4.3 Key growth factors and opportunities
5.4.4 Market size and forecast
5.5 Mass Spectrometry
5.5.1 Key market trends
5.5.2 Competitive scenario
5.5.3 Key growth factors and opportunities
5.5.4 Market size and forecast
5.6 Others
5.6.1 Key market trends
5.6.2 Competitive scenario
5.6.3 Key growth factors and opportunities
5.6.4 Market size and forecast
CHAPTER 6 GLOBAL DNA DIAGNOSTICS MARKET BY APPLICATIONS, 2013-2020
6.1 Oncology
6.1.1 Prostate Cancer
6.1.2 Breast Cancer
6.1.3 Colorectal Cancer
6.1.4 Others
6.2 Infectious disease testing
6.2.1 Hepatitis B Virus (HBV)
6.2.2 Hepatitis C Virus (HCV)
6.2.3 Human Immunodeficiency Virus (HIV)
6.2.4 Tuberculosis (TB)
6.2.5 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.6 Human Papillomavirus (HPV)
6.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.8 Others
6.3 Myogenic disorder diagnosis
6.4 Clinical diagnosis confirmation
6.5 Prenatal diagnosis
6.6 Pre-implantation diagnosis
6.7 Others
CHAPTER 7 GLOBAL DNA DIAGNOSTIC MARKET BY END-USERS, 2013-2020
7.1 Point of Care
7.2 Central Laboratories/Diagnostic Centers
7.3 Self Testing/OTC
CHAPTER 8 GLOBAL DNA DIAGNOSTIC MARKET BY GEOGRAPHY, 2013-2020
8.1 North America
8.1.1 Key market trends
8.1.2 Competitive scenario
8.1.3 Key growth factors and opportunities
8.1.4 Market size and forecast
8.1.5 United States
8.1.6 Canada
8.1.7 Mexico
8.2 Europe
8.2.1 Key market trends
8.2.2 Competitive scenario
8.2.3 Key growth factors and opportunities
8.2.4 Market size and forecast
8.2.5 France
8.2.6 Germany
8.2.7 United Kingdom
8.2.8 Others
8.3 Asia-Pacific
8.3.1 Key market trends
8.3.2 Competitive scenario
8.3.3 Key growth factors and opportunities
8.3.4 Market size and forecast
8.4 LAMEA
8.4.1 Key market trends
8.4.2 Competitive scenario
8.4.3 Key growth factors and opportunities
8.4.4 Market size and forecast
8.4.5 Latin America
8.4.6 Middle East
8.4.7 Africa
CHAPTER 9 ASIA PACIFIC DNA DIAGNOSTIC MARKET ANALYSIS 2013-2020
9.1 Market dynamics
9.2 Key market trends
9.3 Clinical trials
9.4 Government regulations
9.5 Company analysis by region
9.5.1 India
9.5.1.1 Genome Diagnostics Pvt. Ltd.
9.5.1.2 Transasia
9.5.1.3 Dr Reddy’s lab
9.5.2 china
9.5.3 Australia
9.5.3.1 Genera biosystems
9.5.4 Japan
9.5.4.1 Sysmex
CHAPTER 10 COMPANY PROFILES
10.1 Sysmex
10.1.1 Company Overview
10.1.2 Company Snapshot
10.1.3 Financial performance
10.1.4 Strategic moves and developments
10.1.4.1 Primary Strategy: product launch
10.1.4.2 secondary Strategy: collaboration and partnership
10.1.5 SWOT analysis
10.2 Bayer Diagnostic
10.2.1 Overview
10.2.2 Company snapshot
10.2.3 Financial performance
10.2.4 Strategic moves and developments
10.2.4.1 Primary Strategy: product launch
10.2.5 SWOT analysis
10.3 Roche Diagnostics
10.3.1 Overview
10.3.2 Company snapshot
10.3.3 Financial performance
10.3.4 Strategic moves and developments
10.3.4.1 Primary Strategies:product launch
10.3.4.2 Secondary Strategy: Collaboration
10.3.5 SWOT analysis
10.4 Abbott Laboratories
10.4.1 Overview
10.4.2 Company snapshot
10.4.3 Financial performance
10.4.4 Strategic moves and developments
10.4.4.1 Primary Strategies: product launch
10.4.5 SWOT analysis
10.5 Cephide Inc.
10.5.1 Overview
10.5.2 Company snapshot
10.5.3 Financial performance
10.5.4 Strategic moves and developments
10.5.4.1 Primary Strategies: partnership and product launch
10.5.4.2 Secondary Strategy: Collaboration
10.5.5 SWOT analysis
10.6 Gen-probe Inc. (Hologic)
10.6.1 Overview
10.6.2 Company snapshot
10.6.3 Financial performance
10.6.4 Strategic moves and developments
10.6.4.1 Primary Strategy: product launch
10.6.5 SWOT analysis
10.7 Illumina, Inc.
10.7.1 Overview
10.7.2 Company snapshot
10.7.3 Financial performance
10.7.4 Strategic moves and developments
10.7.4.1 Primary Strategies: partnership and product launch
10.7.5 SWOT analysis
10.8 Thermo Fisher Scientific
10.8.1 Overview
10.8.2 Company snapshot
10.8.3 Financial performance
10.8.4 Strategic moves and developments
10.8.4.1 Primary Strategies:product launch
10.8.4.2 Secondary Strategy: Collaborationand acquisition
10.8.5 SWOT analysis
10.9 Bio-Rad Laboratories
10.9.1 Overview
10.9.2 Company snapshot
10.9.3 Financial performance
10.9.4 Strategic moves and developments
10.9.4.1 Primary Strategies: product launch
10.9.4.2 Secondary Strategies: Acquistaion
10.9.5 SWOT analysis
10.10 Johnson and Johnson
10.10.1 Overview
10.10.2 Company snapshot
10.10.3 Financial performance
10.10.4 Strategic moves and developments
10.10.4.1 Primary strategies: collaboration
10.10.5 SWOT analysis
10.11 Novartis
10.11.1 Overview
10.11.2 Company snapshot
10.11.3 Financial performance
10.11.4 Strategic moves and developments
10.11.4.1 Primary Strategies: product launch
10.11.4.2 secondary Strategies: collaboration and partnership
10.11.5 SWOT analysis
LIST OF TABLES
TABLE 1 Dna diagnostic market moderate growth scenario by geography, 2020-2025 ($Million)
TABLE 2 Dna diagnostic market rapid growth scenario by geography, 2020-2025 ($Million)
TABLE 3 Dna diagnostic market diminishing growth scenario by geography, 2020-2025 ($Million)
TABLE 4 Milestone of FDA guidelines for personalized medicines
TABLE 5 Clinical trials conducted for DNA diagnostics technologies
TABLE 6 Chronic Disease Prevalence
TABLE 7 Types of DNA diagnostic devices by technology
TABLE 8 Global dna diagnostic market revenue by product types, 2013-2020 ($Million)
TABLE 9 Global Instrument dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 10 Global reagents dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 11 Global software & services dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 12 Global dna diagnostic market revenue by technology 2013-2020 ($Million)
TABLE 13 Global PCR technology market revenue by geography: 2020-2025 ($Million)
TABLE 14 Microarray technology pricing chart
TABLE 15 Global Microarray technology market revenue by geography, 2013-2020 ($Million)
TABLE 16 In situ hybridization devices pricing chart
TABLE 17 Global In situ hybridization technology market revenue by geography, 2013-2020 ($Million)
TABLE 18 Global sequencing technology market revenue by market revenue by geography, 2013-2020 ($Million)
TABLE 19 laboratory equipment prices
TABLE 20 Global mass spectrometry market revenue by geography, 2013-2020 ($Million)
TABLE 21 Global other technology market revenue by geography, 2013-2020 ($Million)
TABLE 22 Global dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 23 Global oncology dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 24 Global Infectious diseases dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 25 Global Myogenic disorder dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 26 Global Clinical dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 27 Global Prenatal dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 28 Global Per-implantation dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 29 Other dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 30 Global dna diagnostic market revenue by end users: 2013-2020 ($Million)
TABLE 31 Global point of care dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 32 Global diagnostic center dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 33 Global Self testing/OTC dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 34 United states dna diagnostics market revenue by application, 2013-2020 ($ million)
TABLE 35 Canada dna diagnostic market revenue by application, 2013-2020 ($ million)
TABLE 36 Mexico dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 37 France dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 38 Germany dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 39 United kingdom dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 40 Others dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 41 Asia pacific dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 42 lamea dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 43 LAtin america dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 44 Middle east dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 45 Africa dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 46 Company snapshot of Sysmex
TABLE 47 Company snapshot of Bayer Diagnostic
TABLE 48 Company snapshot of Roche DIAGNOSTICS
TABLE 49 Company snapshot of Abbott Laboratories
TABLE 50 Company snapshot Cephide inc
TABLE 51 Company snapshot of Gen-probe Inc. (Hologic)
TABLE 52 Company snapshot of Illumina, Inc.
TABLE 53 Company snapshot of Thermo Fisher Scientific
TABLE 54 Company snapshot of Bio-Rad Laboratories
TABLE 55 Company snapshot of Johnson & Johnson
TABLE 56 Company snapshot of Novartis
LIST OF FIGURES
FIG.1 Top Factors Impacting on DNA Diagnostics market
FIG.2 Top Investment Pockets of DNA Diagnostics market
FIG.3 Top winning strategies for DNA diagnostic market during 2010-2014
FIG.4 Recent development of DNA diagnostic market by companies (2010-2014)
FIG.5 Top wining strategies by subtype of developments
FIG.6 Porter’s Five force Analysis of DNA DIagnostics market
FIG.7 Value chain analysis of Dna diagnostics market
FIG.8 Patent analysis by geographies (2010-2014)
FIG.9 Patent analysis of Sub Segment(2010-2014)
FIG.10 Market share analysis of DNA diagnostics market
FIG.11 Factors affecting the commercial potential of companies developing a molecular diagnostic
FIG.12 Net sales by geographic region (2013)
FIG.13 SWOT analysis of sysmex
FIG.14 Revenue generated
FIG.15 Revenue generation by segments
FIG.16 Swot analysis of Bayer
FIG.17 Net diagnostic sales by geography (2013)
FIG.18 SWOT analysis of roche Diagnostics
FIG.19 Net revenue generation by abbott (2012-2013)
FIG.20 Net revenue generation by segments (2013)
FIG.21 SWOT analysis of abbott LABORATORIES
FIG.22 Net sales by geography (2013)
FIG.23 Net sales by clinical and non clinical market(2013)
FIG.24 SWOT analysis of cepheid inc.
FIG.25 Revenue generated by the company in 2011 and 2012
FIG.26 SWOT analysis of Gen-probe Inc. (Hologic)
FIG.27 Net revenue generation (2012-2013)
FIG.28 SWOT analysis of ILLUMINA, INC.
FIG.29 Net sales by segments (2013)
FIG.30 Revenue generation (2011-2013)
FIG.31 Revenue genetaration by segments (2013)
FIG.32 Swot analysis of Thermo Fisher Scientific
FIG.33 Net revenue generation (2011-2013)
FIG.34 Net sales by segments (2013)
FIG.35 Net sales by geogrephy (2013)
FIG.36 SWOT analysis of bio-rad laboratories
FIG.37 Revenue generation by Segment (2013)
FIG.38 Revenues generation by Geography (2013)
FIG.39 SWOT analysis of johnson & johnson
FIG.40 Net revenue generation by geography (2013)
FIG.41 Net revenue generation by businesses (2013)
FIG.42 SWOT analysis of Novartis
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : November 2019
$ 3600
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
